<DOC>
	<DOCNO>NCT01401010</DOCNO>
	<brief_summary>Primary : To determine serum pharmacokinetics ( PK ) doripenem febrile neutropenic patient . Secondary : Monte Carlo Simulations Tested Against Various Gram-negative Isolates Reported Probability Target Attainment ( 40 % Time ( fT ) &gt; minimum inhibitory concentration ( MIC ) )</brief_summary>
	<brief_title>Pharmacokinetic/Pharmacodynamic Study Doripenem Febrile Neutropenic Patients</brief_title>
	<detailed_description>Background : Doripenem group 2 carbapenem enhance vitro activity Gram-negative bacteria include Pseudomonas aeruginosa . Currently , paucity pharmacokinetic/pharmacodynamic data doripenem patient febrile neutropenia . Objectives : To conduct pharmacokinetic safety evaluation two dos doripenem febrile neutropenic patient provide probability estimate attain effective drug exposure common Gram-negative pathogen . Methods : We obtain multiple blood sample 12 adult patient febrile neutropenia receive either 500 mg 1000 mg doripenem IV 4-hours every 8 hour . Following least 2 dos , serum concentration measure subject 1 , 4 , 6 8 hour initiation dose validate HPLC assay . The derive pharmacokinetic ( PK ) parameter serum level utilize perform 5000 patient Monte Carlo simulation bacteria minimal inhibitory concentration ( MICs ) 0.008 64 mg/L determine probability estimate time free drug concentration &gt; MIC ( fT &gt; MIC ) . Results : The mean PK parameter patient volume distribution ( Vd ) 43.9L , elimination rate constant ( k ) 0.37 hr -1 , total clearance ( Cl ) 14.4 L/h , area concentration-time curve ( AUC ) 57.6 mg∙h/L . An optimal probability target attainment ( 40 % fT &gt; MIC ) 90 % obtain bacteria MICs ≤ 2.0 ≤ 4.0 mg/L 500 mg 1000 mg dos , respectively . Adverse event associate doripenem observed patient . Conclusions : The finding analysis doripenem suggest high dos well prolonged infusion may necessary optimally treat select Gram-negative bacteria ( eg . Pseudomonas aeruginosa ) patient febrile neutropenia</detailed_description>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<criteria>adult neutropenic ( &lt; 500 cell ) patient febrile Patients Creatinine Clearance &lt; 30 ml/min allergy carbapenems exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>neutropenia</keyword>
	<keyword>doripenem</keyword>
</DOC>